Translate
About
Maxcyte Inc (NASDAQ:MXCT) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 31 2026
MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 24 2026
MaxCyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance
Mar 23 2026
MaxCyte Appoints Parmeet Ahuja as Chief Financial Officer
Feb 24 2026
MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery
Feb 23 2026
MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026
Financials
Revenue
$33.03 M
Market Cap
$80.1 M
EPS
-0.42